Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Künstliche Intelligenz (KI)-gestützte Früherkennung Der Diabetischen Retinopathie (FUNDUS-KI)

NCT07378891 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT07378891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07378891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Künstliche Intelligenz (KI)-gestützte Früherkennung Der Diabetischen Retinopathie (FUNDUS-KI)
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Enrolling by invitation
Start date
December 1, 2025
Completion date
December 15, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes (dm), prediabetes